Skip to main content
Equibles

Bank of New York Mellon Corp

Bank

Position in TSHA — Taysha Gene Therapies, Inc.

CIK 1390777 NEW YORK, NY
Back to TSHA Full portfolio

Position in TSHA

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$4,753,180
+$2,034,872 QoQ
Shares Held
697,971
+14.8% QoQ
Ownership
0.214%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#47
of 208 holders
Holding Since
Dec 2020
19 quarters on record
Voting authority Sole 84% Shared 0% None 16%

Common Shares in TSHA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Bank of New York Mellon Corp holds $4,864,365,655 across 311 Biotechnology names. TSHA ranks #101 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,672,623 $830,842,010
2 REGN
Regeneron Pharmaceuticals, Inc.
 758,492 $472,950,091
3 JAZZ
Jazz Pharmaceuticals plc
 1,578,013 $380,253,782
4 ALNY
Alnylam Pharmaceuticals, Inc.
 492,071 $148,128,128
5 INSM
INSMED Inc
 1,312,756 $139,966,036
6 MRNA
Moderna, Inc.
 1,701,675 $119,168,293
7 RVMD
Revolution Medicines, Inc.
 601,056 $112,565,759
8 INCY
Incyte Corp
 972,825 $110,279,435

All Filings in TSHA

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,753,180 697,971
2026-03-31 $2,718,308 608,123
2025-12-31 $3,434,018 624,367
2025-09-30 $2,043,222 624,839
2025-06-30 $1,059,501 458,659
2025-03-31 $630,253 453,420
2024-12-31 $778,950 450,261
2024-09-30 $679,925 338,272
2024-06-30 $1,017,998 454,464
2023-12-31 $102,907 58,140
2023-09-30 $82,393 26,074
2022-09-30 $21,799 11,295
2022-06-30 $43,412 11,670
2022-03-31 $510,104 78,237
2021-12-31 $887,380 76,170
2021-09-30 $1,373,131 73,745
2021-06-30 $1,201,446 56,672
2021-03-31 $546,719 26,932
2020-12-31 $716,048 26,980